NASDAQ$HAIN

Hain Celestial · Q2 2025 earnings

Q2 2025 earnings · · Before market open · Investor relations

Briefing

Hain Celestial's financial performance declined due to challenges in snacks and personal care, but strong operating cash flow and debt reduction were achieved.

Hain Celestial reported a decrease in net sales and a net loss for Q2 2025. Despite these challenges, the company generated strong operating cash flow and reduced its debt. The company is exploring strategic options for its personal care business.

  • Net sales decreased by 9% year-over-year to $411 million.
  • Organic net sales decreased by 7% compared to the prior year period.
  • Net loss was $104 million, including $107 million in non-cash impairment charges.
  • Adjusted EBITDA was $38 million, with a margin of 9.2%.

Headline financials

Total Revenue

$411M

Previous: $454M-9.4%
EPS (adj)

$0.08

Previous: -$0.15+153.3%
Gross Margin

22.7%

No prior period
Adjusted Gross Margin

22.9%

No prior period
Adjusted EBITDA

$37.9M

No prior period
Adjusted EBITDA Margin

9.2%

No prior period
Net Loss Margin

-25.3%

No prior period
Adjusted Net Income Margin

1.8%

No prior period
Organic Net Sales Decline

-6.7%

No prior period
Capital Expenditures

-$12.1M

Previous: -$12.7M+4.7%
Net Income

-$104M

Previous: -$13.5M-668.4%
Operating Income

-$91.9M

Previous: -$781K-11666.8%
Gross Profit

$93.5M

Previous: $102M-8.6%

Revenue & EPS history

Hain Celestial · Revenue · Quarterly

$411M

Q2 2025-9.4%vs Q2 2024
Beat estimate in 7 of 15 quarters(47%)
ActualEstimate

Revenue by segment

Hain Celestial · $425M total across 2 segments · Q1 2024

  • North America
    $260M-9.8%
  • International
    $165M+9.3%

Forward guidance

Hain Celestial revised its fiscal 2025 guidance, expecting organic net sales to decline by 2-4%, adjusted EBITDA to be flat year-over-year, gross margin to increase by at least 90 basis points, and free cash flow to be at least $60 million.

Tailwinds

  • Company has taken steps to address commercial execution and supply chain challenges.
  • Recent distribution wins.
  • Recovery of infant formula supply.
  • Gross margin is expected to increase by at least 90 basis points.
  • Free cash flow is expected to be at least $60 million.

Headwinds

  • Commercial execution and supply chain challenges impacted Q2 results.
  • Challenging macroeconomic backdrop.
  • Organic net sales growth is expected to be down 2 to 4%.
  • Adjusted EBITDA is expected to be flat year-over-year.
  • Performance to date was below expectations.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q2 2025

Historical avgQ2 2025

-1.5%

Avg return

Earnings day

-1.9%

Avg return

5 days after

-2.3%

Avg return

30 days after

46%

31 / 67 earnings

Positive

+20.9%

Q4 2024

Best reaction

-48.4%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2026+12.9%+17.4%-3.7%
Q2 2026-19.5%-22.0%-48.0%
Q1 2026+14.4%+32.7%-3.7%
Q3 2025-48.4%-36.1%-36.1%
Q2 2025-10.7%-13.6%-11.3%
Q1 2025-16.7%-24.9%-7.1%
Q4 2024+20.9%+17.1%+20.9%
Q3 2024+5.6%+14.1%+13.4%
Q2 2024-11.9%-12.7%-17.4%
Q1 2024-6.0%-3.6%-6.7%
Q4 2023-2.5%-9.1%-16.4%
Q3 2023-14.4%-19.8%-31.0%
Q2 2023-10.0%-12.8%-19.6%
Q1 2023+1.4%+10.6%-8.1%
Q4 2022-13.9%-17.0%-31.1%
Q3 2022-24.9%-20.7%-22.6%
Q2 2022+1.4%+2.1%-5.9%
Q1 2022+5.0%-9.0%-14.9%
Q4 2021-9.7%-6.5%+0.1%
Q3 2021+0.0%-0.9%+0.2%
Q2 2021+4.5%+6.2%+7.3%
Q1 2021+2.1%+11.9%+13.8%
Q4 2020-4.4%-7.5%-4.3%
Q3 2020+10.9%+16.7%+11.3%
Q2 2020+9.3%+7.6%-6.2%
Q1 2020+7.0%+5.7%+3.9%
Q4 2019+3.8%+4.4%+17.3%
Q3 2019-3.7%+0.6%-11.5%
Q2 2019-10.6%+1.5%+20.9%
Q1 2019-14.9%-15.5%-26.1%
Q4 2018-3.6%-0.2%-7.5%
Q3 2018-2.2%-2.5%-3.4%
Q2 2018-5.5%-8.7%-2.3%
Q1 2018+1.6%+3.8%+19.0%
Q4 2017-2.4%-2.6%+0.2%
Q3 2017-4.7%+4.8%+32.0%
Q1 2017-4.7%+4.8%+32.0%
Q2 2017-4.7%+4.8%+32.0%
Q4 2016-4.7%+4.8%+32.0%
Q3 2016+9.0%
Q2 2016-4.2%
Q1 2016-4.8%
Q4 2015-6.2%
Q3 2015-0.5%
Q2 2015+6.2%
Q1 2015+1.0%
Q4 2014+10.2%
Q3 2014+8.0%
Q2 2014-4.5%
Q1 2014+3.8%
Q4 2013+9.5%
Q3 2013-1.8%
Q2 2013+1.0%
Q1 2013-1.0%
Q4 2012+19.4%
Q3 2012-0.6%
Q2 2012+1.5%
Q1 2012-1.3%
Q4 2009+1.0%
Q4 2011+1.0%
Q3 2011+1.5%
Q3 2010+1.5%
Q2 2011+1.6%
Q2 2010+1.6%
Q4 2010-0.8%
Q1 2010-0.8%
Q1 2011-0.8%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro